Publication

Article

BioPharm International

BioPharm International-02-01-2013
Volume26
Issue 2

BioPharm International, February 2013 Issue (PDF)

Viral Vaccines

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue
BioPharm International, February 2013 Issue (PDF)
TinaSatterwhite-804371-1408545030485.jpg
Assessing Development Needs for Biobetters and Biosimilars
Mike-Lacey-804368-1416910184930.jpg
Facility Design and Operation: A Primer
Aaron-Davidson-804372-1408545028367.jpg
Offering a Biopharma View of Social Media
Jill_Wechsler-804365-1408545042131.jpg
GMP Compliance Becomes Prominent Enforcement Issue
Morrow-Antibodies-Figure-2-804370-1408545032289.jpg
Therapeutic Antibodies in Review

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, CSO, AustinPx
Related Content
Businessman look at higher career barriers ambitious to overcome | Image Credit: © Lerbank-bbk22 - stock.adobe.com
August 14th 2025

Biopharma Development Hurdles: Lessons from Vedanta’s Live Bacteria Cocktail Failure

Christopher Cole
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
August 14th 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
Site Logo
August 14th 2025

Decentralized Trials: The Value of Direct-to-Patient & Pharmacy-Led Solutions

Mastering Antibody-Drug Conjugates
August 14th 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
Site Logo
August 14th 2025

Tech Transfer and Scale-Up of E. coli Fermentation: BIOVECTRA & ABEC Collaboration

Site Logo
August 14th 2025

European Clinical Supply Planning – Balancing Cost, Flexibility & Time

© 2025 MJH Life Sciences

All rights reserved.